Sarah L Becker, Gina N Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M Drucker, Jonathan Silverberg, Lawrence F Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, Eric Simpson
{"title":"提高美国特应性皮炎流行病学研究的质量——对疾病定义和国家调查中相关内容的系统回顾。","authors":"Sarah L Becker, Gina N Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M Drucker, Jonathan Silverberg, Lawrence F Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, Eric Simpson","doi":"10.1016/j.jid.2025.07.025","DOIUrl":null,"url":null,"abstract":"<p><p>Epidemiologic studies of atopic dermatitis (AD) are critical to improve our understanding of the disease burden and to identify numerous atopic and nonatopic comorbidities. Despite their widespread use, the definitions and related contents of AD in population-based surveys have not been comprehensively evaluated. To characterize the state of population-based health-related surveys in the United States that include AD or eczema, we conducted a systematic review of Ovid MEDLINE to study AD in the United States from database inception through March 26, 2025. Of the 916 articles screened, 24 were included in the analysis, which included 11 independent surveys. Most surveys rely on self-reporting of physician diagnosis of AD or the International Study of Asthma and Allergies in Childhood criteria, including a modified version of the International Study of Asthma and Allergies in Childhood criteria, which has not been validated. National surveys yield the largest sample and are typically repeated annually; however, some national surveys have not included questions on AD in recent years. National surveys do not use standardized definitions to identify AD and do not adequately capture the key aspects of AD burden. Therefore, future population-based surveys should address these issues.</p>","PeriodicalId":94239,"journal":{"name":"The Journal of investigative dermatology","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improving the Quality of Atopic Dermatitis Epidemiologic Research in the United States: A Systematic Review of Disease Definitions and Related Content in National Surveys.\",\"authors\":\"Sarah L Becker, Gina N Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M Drucker, Jonathan Silverberg, Lawrence F Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, Eric Simpson\",\"doi\":\"10.1016/j.jid.2025.07.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Epidemiologic studies of atopic dermatitis (AD) are critical to improve our understanding of the disease burden and to identify numerous atopic and nonatopic comorbidities. Despite their widespread use, the definitions and related contents of AD in population-based surveys have not been comprehensively evaluated. To characterize the state of population-based health-related surveys in the United States that include AD or eczema, we conducted a systematic review of Ovid MEDLINE to study AD in the United States from database inception through March 26, 2025. Of the 916 articles screened, 24 were included in the analysis, which included 11 independent surveys. Most surveys rely on self-reporting of physician diagnosis of AD or the International Study of Asthma and Allergies in Childhood criteria, including a modified version of the International Study of Asthma and Allergies in Childhood criteria, which has not been validated. National surveys yield the largest sample and are typically repeated annually; however, some national surveys have not included questions on AD in recent years. National surveys do not use standardized definitions to identify AD and do not adequately capture the key aspects of AD burden. Therefore, future population-based surveys should address these issues.</p>\",\"PeriodicalId\":94239,\"journal\":{\"name\":\"The Journal of investigative dermatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of investigative dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jid.2025.07.025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of investigative dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jid.2025.07.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Improving the Quality of Atopic Dermatitis Epidemiologic Research in the United States: A Systematic Review of Disease Definitions and Related Content in National Surveys.
Epidemiologic studies of atopic dermatitis (AD) are critical to improve our understanding of the disease burden and to identify numerous atopic and nonatopic comorbidities. Despite their widespread use, the definitions and related contents of AD in population-based surveys have not been comprehensively evaluated. To characterize the state of population-based health-related surveys in the United States that include AD or eczema, we conducted a systematic review of Ovid MEDLINE to study AD in the United States from database inception through March 26, 2025. Of the 916 articles screened, 24 were included in the analysis, which included 11 independent surveys. Most surveys rely on self-reporting of physician diagnosis of AD or the International Study of Asthma and Allergies in Childhood criteria, including a modified version of the International Study of Asthma and Allergies in Childhood criteria, which has not been validated. National surveys yield the largest sample and are typically repeated annually; however, some national surveys have not included questions on AD in recent years. National surveys do not use standardized definitions to identify AD and do not adequately capture the key aspects of AD burden. Therefore, future population-based surveys should address these issues.